Health Catalyst (HCAT) Misses Q4 EPS by 40c

Health Catalyst (NASDAQ: HCAT) reported Q4 EPS of ($0.33), $0.40 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $79.6 million versus the consensus estimate of $80.68 million.

For earnings history and earnings-related data on Health Catalyst (HCAT) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Phillips 66, Marathon Merger Talks Collapsed - Semafor
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c